Prevalence and incidence of sarcopenia in Swiss postmenopausal women: findings from the OsteoLaus Cohort
Swiss Medical Weekly · 2025
DOI: 10.57187/s.4034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Swiss Medical Weekly, 2025. Verfasst von Colin Vendrami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Centre of Bone Diseases, Rheumatology Unit, Bone and Joint Department, Lausanne University Hospital and University of Lausanne, Lau…. Hauptthemen laut MEDLINE: Sarcopenia, Postmenopause. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
STUDY AIMS: Sarcopenia is a progressive, age-related loss of muscle mass, strength and function. Given the ageing population and the adverse outcomes associated with sarcopenia, monitoring its epidemiology is particularly important. This study aimed to describe sarcopenia prevalence, 5-year incidence and agreement between definitions using the latest operational criteria in Swiss postmenopausal women. METHODS: Postmenopausal women from the last 5 years of the CoLaus/OsteoLaus prospective population-based cohort were included based on complete case analysis (April 2015 to October 2022; Lausanne, Switzerland). We assessed appendicular lean mass via Dual X-ray Absorptiometry (GE Lunar iDXA), handgrip strength using a Jamar Dynamometer and 6-metre gait speed at multiple visits. Sarcopenia was defined based on handgrip strength and/or appendicular lean mass and/or gait speed using 11 definitions, including that from the European Working Group on Sarcopenia in Older People (EWGSOPII, 2019). Prevalence was measured as the number and rate of sarcopenic cases at the last visit, while incidence was measured as the number and rate of new sarcopenic cases over 2.5 or 5 years. RESULTS: A total of 930 women were included, with a mean (standard deviation) age of 72.9 (6.9) years, BMI of 25.7 (4.8) kg/m2, appendicular lean mass 16.8 (2.5) kg, handgrip strength 21.2 (5.5) kg, gait speed 1.1 (0.2) m/s. Sarcopenia prevalence based on EWGSOPII definitions ranged from 2.2% to 5.7%, while other definitions varied from 0.5% to 13.4%. The 5-year incidence rates based on EWGSOPII were 1.9% to 4.7%. Prevalence and incidence increased significantly between the lowest and highest age tertiles (Fisher’s exact test, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Interdisciplinary Centre of Bone Diseases, Rheumatology Unit, Bone and Joint Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Department of Medicine, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Vendrami, C., Gonzalez Rodriguez, E., Gatineau, G., Vollenweider, P., Marques-Vidal, P., Lamy, O., Hans, D., & Shevroja, E. (2025). Prevalence and incidence of sarcopenia in Swiss postmenopausal women: findings from the OsteoLaus Cohort. Swiss Medical Weekly. https://doi.org/10.57187/s.4034
Vancouver
Vendrami C, Gonzalez Rodriguez E, Gatineau G, Vollenweider P, Marques-Vidal P, Lamy O, et al. Prevalence and incidence of sarcopenia in Swiss postmenopausal women: findings from the OsteoLaus Cohort. Swiss Medical Weekly. 2025. doi:10.57187/s.4034
BibTeX
@article{Vendrami2025,
author = {Vendrami, Colin and Gonzalez Rodriguez, Elena and Gatineau, Guillaume and Vollenweider, Peter and Marques-Vidal, Pedro and Lamy, Olivier and Hans, Didier and Shevroja, Enisa},
title = {Prevalence and incidence of sarcopenia in Swiss postmenopausal women: findings from the OsteoLaus Cohort},
journal = {Swiss Medical Weekly},
year = {2025},
doi = {10.57187/s.4034}
}
EUVIMED